Safety and efficacy of treatment using interleukin-2 in a patient with idiopathic CD4 + lymphopenia and Mycobacterium avium-intracellulare

Clinical and Experimental Immunology

Volumn 156, Issue 3, 2009, Pages 440-445

  Trojan, T ^a,b   Collins, R ^c   Khan, D A ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Texas Southwestern Medical Allergy and Immunology   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

ICL; IL 2 treatment; Lymphopenia; MAI; T cell

Indexed keywords

CLARITHROMYCIN; FLUTICASONE PROPIONATE PLUS SALMETEROL; INTERLEUKIN 2;

ADULT; ARTICLE; ASTHMA; ATYPICAL MYCOBACTERIOSIS; CASE REPORT; CD4 LYMPHOCYTE COUNT; CHRONIC BRONCHITIS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EOSINOPHILIA; FATIGUE; FLU LIKE SYNDROME; HUMAN; IDIOPATHIC CD4+ LYMPHOPENIA; LYMPHADENOPATHY; LYMPHOCYTOPENIA; MAINTENANCE DRUG DOSE; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; SPUTUM CULTURE;

ADULT; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; INTERLEUKIN-2; LYMPHOPENIA; MALE; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; OPPORTUNISTIC INFECTIONS;

EID: 66149153466     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03910.x     Document Type: Article

References (28)

1. Unexplained CD4+ T-lymphocyte depletion in persons without evident HIV infection - United States. MMWR 1992 41 : 541.
2. Laurence J, Siegal FP, Schattner E, Gelman IH, Morse S. Acquired immunodeficiency without evidence of infection with human immunodeficiency virus types 1 and 2. Lancet 1992 340 : 273 4.
3. Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med 1993 328 : 373.
4. Ho DD, Cao Y, Zhu T et al. Idiopathic CD4+ T lymphopenia (ICL): immunodeficiency without evidence of human immunodeficiency virus infection. N Engl J Med 1993 328 : 380 6. (Pubitemid 23042285)
5. Spira TJ, Jones BM, Nicholson JKA et al. Idiopathic CD4+ T lymphocytopenia - an analysis of five patients with unexplained opportunistic infections. N Engl J Med 1993 328 : 86 92. (Pubitemid 23042286)
6. Duncan RA, Von Reyn CF, Alliegro GM, Toossi Z, Sugar AM, Levitz SM. Idiopathic CD4+ T lymphocytopenia - four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med 1993 328 : 393 8. (Pubitemid 23042287)
7. Aledort LM, Operskalski EA, Dietrich SL et al. CD4+ counts in a study of transfusion safety. N Engl J Med 1993 328 : 441 2. (Pubitemid 23042297)
8. + lymphocytopenia: natural history and prognostic factors. Blood 2008 112 : 287 94.
9. DeHovitz JA, Feldman J, Landesman S. Idiopathic CD4+ T-lymphocytopenia. N Engl J Med 1993 329 : 1045 6. (Pubitemid 23307922)
10. + T cells but not CD8+ or γΔ+ lymphocytes are required for host protection against Mycobacterium avium infection and dissemination through the intestinal route. Infect Immun 2005 73 : 2621 7. (Pubitemid 40570327)
11. Shiratsuchi H, Krukovets I, Ellner JJ. Role of T cell subsets in the modulation of Mycobacterium avium growth within human monocytes. Cell Immunol 2000 202 : 6 12. (Pubitemid 30445641)
12. Cunningham-Rundles C, Murray HW, Smith JP. Treatment of idiopathic CD4 T lymphocytopenia with IL-2. Clin Exp Immunol 1999 116 : 322 5. (Pubitemid 29219731)
13. Warnatz K, Draeger R, Schlesier M, Peter HH. Successful IL-2 therapy for relapsing herpes zoster infection in a patient with idiopathic CD4+ T lymphocytopenia. Immunobiology 2000 202 : 204 11. (Pubitemid 30639251)
14. Wilhelm M, Weissinger F, Kunzmann V, Muller JG, Fahey JL. Idiopathic CD4+ T cell lymphocytopenia evolving to monoclonal immunoglobulins and progressive renal damage responsive to IL-2 therapy. Clin Immunol 2001 99 : 298 04. (Pubitemid 32458056)
15. Yilmaz-Demirdag Y, Wilson B, Lowery-Nordberg M, Bocchini JA, Bahna SL. Interleukin-2 treatment for persistent cryptococcal meningitis in a child with idiopathic CD4(+) T lymphocytopenia. Allergy Asthma Proc 2008 29 : 421 4.
16. Gorlin R, Gelb B, Diaz GA, Lofsness KG, Pittelkow MR, Fenyk JR. WHIM syndrome, an autosomal dominant disorder: clinical, hematological, and molecular studies. Am J Med Genet 2000 91 : 368 76. (Pubitemid 30193934)
17. Ozsahin H, Arredondo-Vega FX, Santisteban I et al. Deaminase deficiency in adults. Blood 1997 89 : 2849 55.
18. Shovlin CL, Simmonds HA, Fairbanks LD et al. Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency. J Immunol 1994 153 : 2331. (Pubitemid 24256705)
19. Ostergaard PA, Deding A, Eriksen J, Mejer J. Common variable immunodeficiency and purine nucleotidase and nucleoside phosphorylase deficiency. A case report. Acta Pathol Microbiol Scand 1980 88 : 299 302. (Pubitemid 11207734)
20. Gatti RA, Boder E, Good RA. Immunodeficiency, radiosensitivity, and the XCIND syndrome. Immunol Res 2007 38 : 87 101. (Pubitemid 47574934)
21. Paganelli R, Scala E, Scarselli E et al. Selective deficiency of CD4+/CD45RA+ lymphocytes in patients with ataxia-telangiectasia. J Clin Immunol 1992 12 : 84 91.
22. Michalkiewicz J, Barth C, Chrzanowska K et al. Abnormalities in the T and natural killer lymphocyte phenotype in patients with Nijmegen breakage syndrome. Clin Exp Immunol 2003 134 : 482 90.
23. + T cell subsets in ataxia telangiectasia. Clin Exp Immunol 2002 129 : 125 32.
24. Mitsuyasu R, Gelman R, Weng Cherng D et al. The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial - AIDS Clinical Trials Group 328. Arch Intern Med 2007 167 : 597 605. (Pubitemid 46513230)
25. Marchetti G, Meroni L, Varchetta S et al. Low dose prolonged intermittent interleukin 2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment. J Infect Dis 2002 186 : 606 16.
26. Emery S, Capra WB, Cooper DA et al. Pooled analysis of 3 randomized, controlled trials of interleukin 2 therapy in adult human immunodeficiency virus type 1 disease. J Infect Dis 2000 182 : 428 34. (Pubitemid 30651038)
27. Jacobson EL, Pilaro F, Smith KA. Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity. Proc Natl Acad Sci USA 1996 93 : 10405 10. (Pubitemid 26314635)
28. Katz P, Yeager H Jr., Whalen G, Evans M, Swartz RP, Roecklein J. Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes. J Clin Immunol 1990 10 : 71 7. (Pubitemid 20085861)